Skip to main content
All lobbying clients

NEUROCRINE BIOSCIENCES, INC.

Lobbying client · California · filed 2025 to 2026

Biotechnology company

$6,780,000 Reported spend
28 Filings counted
4 Outside firms hired
6 Bills named

Spend is reported income plus in-house expenses across 28 filings. 3 further filings for this client were restated by a later amendment and are left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 5 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as NEUROCRINE BIOSCIENCES, INC.

 Who filed for this client 5

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 6
  • HR 3432
    Telemental Health Care Access Act of 2023
    6 filings
  • HR 7024
    Tax Relief for American Families and Workers Act of 2024
    6 filings
  • HR 7623
    Telehealth Modernization Act of 2024
    6 filings
  • HR 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    6 filings
  • HR 946
    ORPHAN Cures Act
    6 filings
  • S 832
    EPIC Act of 2025
    6 filings
 Reported by year 2 years
  • 2026 $2,310,000 8 filings
  • 2025 $4,470,000 20 filings
 Issues lobbied 5

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 6
  • HOUSE OF REPRESENTATIVES 27
  • SENATE 27
  • Centers For Medicare and Medicaid Services (CMS) 12
  • Health & Human Services, Dept of (HHS) 9
  • Executive Office of the President (EOP) 3
  • White House Office 1
 Recent filings 31 total
Q2 report
BGR GOVERNMENT AFFAIRS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 20, 2026
View →
Q2 report
TARPLIN, DOWNS & YOUNG, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $110,000 income · posted Jul 20, 2026
View →
Q2 report
NEUROCRINE BIOSCIENCES, INC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $940,000 expenses · posted Jul 20, 2026
View →
Q2 report
CAPITOL COUNSEL LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $60,000 income · posted Jul 8, 2026
View →
Q1 report
NEUROCRINE BIOSCIENCES, INC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $940,000 expenses · posted Apr 20, 2026
View →
Q1 report
TARPLIN, DOWNS & YOUNG, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $80,000 income · posted Apr 20, 2026
View →
Q1 amendment
BGR GOVERNMENT AFFAIRS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 20, 2026
View →
Q4 termination
LMH STRATEGIC SOLUTIONS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Apr 17, 2026
View →
Q1 report
CAPITOL COUNSEL LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $60,000 income · posted Apr 16, 2026
View →
Q4 report
NEUROCRINE BIOSCIENCES, INC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $900,000 expenses · posted Jan 20, 2026
View →
Q4 report
TARPLIN, DOWNS & YOUNG, LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $80,000 income · posted Jan 20, 2026
View →
Q4 amendment
BGR GOVERNMENT AFFAIRS
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 20, 2026
View →
Q4 report
CAPITOL COUNSEL LLC
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 18, 2026
View →
Q4 report
LMH STRATEGIC SOLUTIONS Amended
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $30,000 income · posted Jan 12, 2026
View →
Q1 report
BGR GOVERNMENT AFFAIRS Amended
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · posted Jan 12, 2026
View →
Q4 report
BGR GOVERNMENT AFFAIRS Amended
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $60,000 income · posted Jan 12, 2026
View →
Q3 report
NEUROCRINE BIOSCIENCES, INC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $900,000 expenses · posted Oct 20, 2025
View →
Q3 report
BGR GOVERNMENT AFFAIRS
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 20, 2025
View →
Q3 report
LMH STRATEGIC SOLUTIONS
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $30,000 income · posted Oct 20, 2025
View →
Q3 report
CAPITOL COUNSEL LLC
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $60,000 income · posted Oct 18, 2025
View →

Showing the 20 most recent of 31 filings. Search the explorer for "NEUROCRINE BIOSCIENCES, INC.".

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem